Dimitri Vegas & Like Mike joined Tomorrowland Winter on November 13
Zoetis stock gets USDA license for three-disease poultry vaccine
SanDisk Pitches 80% Gross Margin Target as Customers Weigh SLC-NAND for AI Agents
Vista Energy stock: UBS lifts price target to 100 dollars
Nasdaq stock set for accounting leadership change in 2027
Vulcan Energy Starts Civils at Lionheart as Landau-Ost Licence Opens a Second Front
Workday stock: Honeydew deal targets enterprise AI adoption
Merck & Co. stock faces board transition as Baker gains new role
Disco Lines plays Race Week in Las Vegas on November 22
Tourmaline Oil stock linked to eight-year SEFE gas deal
DoorDash stock: CEO outlines AI and autonomy growth push
Alicia Keys takes Hellâs Kitchen on tour to Washington on November 24
Verastem stock to present updated VS-7375 lung data on Dec. 5
Lit plays Turtle Lake on December 11 on the Ignited We Stand 2026 Tour
YETI stock: Goldman cuts rating and target after Q3 slowdown
Goldman Sachs stock leads Payhawk's $280 million Series C
Elevance Health stock upgraded to Buy by Argus
Zebra Technologies stock gets guidance boost at Stephens conference
Monster Beverage stock gets Outperform start from Wolfe Research
Iggy Pop was added to Take Cover tour on November 16
Trulieve stock set for preliminary Russell 2000 and 3000 addition
Voestalpine Lifts First-Half EBIT to EUR 470 Million, but War and Tariffs Clip Full-Year Ceiling
SAP Flags Margin Squeeze From Free AI Tools While JPMorgan Bets on a 275-Euro Recovery
Novo Nordisk's CagriSema Hits 21% Weight Loss as EU Clears FREHEMGO
Whitecap Resources stock: November dividend set at CAD 0.0617
Coca-Cola FEMSA stock: Barclays lifts target to USD 128
Super Micro Computer stock faces new AI export curbs
Varonis Systems stock gets US antitrust clearance for Proofpoint deal
J. Cole plays FNB Stadium in Johannesburg on December 12
UniFirst stock faces fresh FTC hurdle in Cintas takeover
Meta Platforms stock pauses Class C issuance pending court case
TELUS stock faces Quebecor's CAD 31 billion bid and regulatory risks
Marsh & McLennan stock upgraded by Wells Fargo with USD 235 target